September 17, 2024- Thermo Fisher Scientific announced the latest recipients of the Oncomine Clinical Research Grant, designed to support emerging research on molecular profiling in oncology and to help democratize the future of precision medicine. Now in its fourth year, the grant recognizes research from Fred Hutch Cancer Center in the U.S., and international health organizations including Tata Memorial Centre in India; Leiden University Center in The Netherlands, and Western University in Canada.
Since its introduction in 2020, the Oncomine Clinical Research Grant program has awarded reagents and general funding for 26 unique research projects conducted by independent clinical research teams.